(USD M) | Mar'21 | Jun'21 | Sep'21 | Dec'21 | Mar'22 | Jun'22 | Sep'22 | Dec'22 | Mar'23 | Jun'23 | Sep'23 | Dec'23 | Mar'24 | Jun'24 | Sep'24 | Dec'24 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
LTM Revenue % growth | 1,001.7 345.9% | 1,066.3 127.4% | 1,111.9 55.1% | 1,167.8 21.7% | 1,246.2 24.4% | 1,303.7 22.3% | 1,370.6 23.3% | 1,434.2 22.8% | 1,527.8 22.6% | 1,623.7 24.5% | 1,720.1 25.5% | 1,823.6 27.2% | 2,013.1 31.8% | 2,232.0 37.5% | 2,467.7 43.5% | 2,703.6 48.3% |
LTM NOPAT % growth | (65.8) N/A | (120.8) 83.7% | (178.2) 47.5% | (194.2) 9.0% | (177.9) (8.4%) | (144.1) (19.0%) | (132.0) (8.4%) | (136.9) 3.8% | (129.2) (5.7%) | (142.0) 9.9% | (138.1) (2.7%) | (127.8) (7.5%) | (136.3) 6.7% | (131.1) (3.9%) | (120.9) (7.8%) | (101.5) (16.0%) |
Discount rate | 8.2% | 8.0% | 8.0% | 7.9% | 8.6% | 9.3% | 10.0% | 10.0% | 9.3% | 9.6% | 10.3% | 9.9% | 9.7% | 10.2% | 9.7% | 10.5% |
Earnings Power Value (EPV) | (804.9) | (1,512.0) | (2,232.7) | (2,454.4) | (2,064.8) | (1,547.7) | (1,316.8) | (1,366.8) | (1,385.9) | (1,481.8) | (1,337.0) | (1,294.6) | (1,404.3) | (1,280.3) | (1,242.7) | (968.2) |
Enterprise Value (EV) | 3,026.5 | 3,745.5 | 2,609.7 | 2,162.7 | 1,728.4 | 1,743.3 | 1,918.9 | 1,744.4 | 895.9 | 782.5 | 953.1 | 1,276.9 | 789.4 | 1,344.6 | 2,043.7 | 1,974.8 |
Market-Implied Value of Growth (MIVoG) | 3,831.4 | 5,257.5 | 4,842.4 | 4,617.2 | 3,793.1 | 3,291.0 | 3,235.7 | 3,111.2 | 2,281.7 | 2,264.4 | 2,290.1 | 2,571.5 | 2,193.7 | 2,624.9 | 3,286.4 | 2,943.0 |
EPV as % of EV | (26.6%) | (40.4%) | (85.6%) | (113.5%) | (119.5%) | (88.8%) | (68.6%) | (78.4%) | (154.7%) | (189.4%) | (140.3%) | (101.4%) | (177.9%) | (95.2%) | (60.8%) | (49.0%) |
MIVoG as % of EV | 126.6% | 140.4% | 185.6% | 213.5% | 219.5% | 188.8% | 168.6% | 178.4% | 254.7% | 289.4% | 240.3% | 201.4% | 277.9% | 195.2% | 160.8% | 149.0% |
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Explore the best low P/E stocks to buy in 2025, featuring top companies trading at low P/E ratios.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
As of Dec 31, 2024, Alignment Healthcare, Inc.'s Earnings Power Value is approximately ($968.2M).
As of Dec 31, 2024, Alignment Healthcare, Inc.'s Enterprise Value (EV) estimates at $1,974.8M.
As of Dec 31, 2024, Alignment Healthcare, Inc.'s Net operating profit after tax (NOPAT) is approximately ($101.5M).